Center For Orthopaedic Rehab is categorized under Physical Therapists in Chicago, IL and active since 2007.
Center For Orthopaedic Rehab was established in 2007, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Physical Therapists business, which does work in the B2C market, and is classified as a Physical Therapists, under code number 6213400 by the NAICS.
If you are seeking more information, feel free to contact David Reavy, Owner at the company’s single location by writing to 939 West Madison St # 103, Chicago, Illinois IL 60607 or by phoning (312) 492-7950. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Center For Orthopaedic Rehab |
| Contact Person: | David Reavy, Owner |
| Address: | 939 West Madison St # 103, Chicago, Illinois 60607 |
| Phone Number: | (312) 492-7950 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physical Therapists |
| SIC Code: | 8049 |
| NAICS Code: | 6213400 |
| Share This Business: |
Center For Orthopaedic Rehab was started in 2007 to provide professional Physical Therapists under the SIC code 8049 and NAICS code 6213400. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact David Reavy, Owner for inquiries that concern Center For Orthopaedic Rehab by calling the company number (312) 492-7950, as your correspondence is most welcome. Additionally, the physical location of the single location of Center For Orthopaedic Rehab can be found at the coordinates 41.881648,-87.651886 as well as the street address 939 West Madison St # 103 in Chicago, Illinois 60607.
For its online presence, you may visit Center For Orthopaedic Rehab’s website at and engage with its social media outlets through on Twitter and on Facebook.